Use of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Department of Health and Human Services said on Tuesday. Nearly 115,000 courses of the pills were dispensed during the first week of May, a senior health…

Read Full Article (External Site)